When Lee Giller’s breast cancer returned in November 2012, he faced a prognosis of 26 months to live. So the 58-year-old Akron businessman, whose estrogen-receptor-positive and BRCA 1 breast cancer had spread to his bones, liver and lungs, said it “didn’t take much...
Our Blog
Partnership to increase clinical trials for cancer treatment
Archbold Medical Center is teaming up with Emory University, to enhance cancer research and treatment. Read more: walb.com
CRISPR: The Path to Clinical Trials
If you have read a newspaper lately, there is a good chance you have heard about CRISPR-Cas9, the versatile gene editing technology. Read more: xconomy.com
Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015 Prevention, Management, Mechanisms, Cause, Signs and Symptoms Report
This report provides top line data relating to the clinical trials on Deep Vein Thrombosis (DVT). Read more: medgadget.com
Treatment Resistant Depression Global Clinical Trials Review, H2, 2015 Market Research Report
This report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Read more: medgadget.com
FDA permits clinical trials of Athenex oral cancer drug
The Buffalo biotech firm Athenex has received U.S. Food and Drug Administration permission to move forward with clinical trials for the oral form of Docetaxel, its highly potent cancer drug, the company announced this week. Read more: buffalonews.com